Histone deacetylase 4 promotes cholestatic liver injury in the absence of prohibitin-1-Reference-Cited by-同舟云学术

Histone deacetylase 4 promotes cholestatic liver injury in the absence of prohibitin-1

Published:2015-07-31 Issue:4 Volume:62 Page:1237-1248
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Barbier-Torres Lucía¹,Beraza Naiara¹,Fernández-Tussy Pablo¹,Lopitz-Otsoa Fernando¹,Fernández-Ramos David¹,Zubiete-Franco Imanol¹,Varela-Rey Marta¹,Delgado Teresa C.¹,Gutiérrez Virginia¹,Anguita Juan²,Pares Albert³,Banales Jesús M.⁴,Villa Erica⁵,Caballería Juan³,Alvarez Luis⁶,Lu Shelly C.⁷,Mato Jose M.¹,Martínez-Chantar María Luz¹

Affiliation:

1. CIC bioGUNE, Metabolomics Unit; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd); Bizkaia Spain

2. CIC bioGUNE, Proteomics Unit; Bizkaia Spain

3. Liver Unit, Hospital Clínic, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd); IDIBAPS; Barcelona Spain

4. Biodonostia Research Health Institute, Donostia University Hospital (HUD), University of the Basque Country (UPV/EHU), Ikerbasque, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd); San Sebastian Spain

5. Department of Gastroenterology; Azienda Ospedaliero-Universitaria and University of Modena and Reggio Emilia; Modena Italy

6. La Paz University Hospital Health Research Institute-IdiPAZ; Madrid Spain

7. Division of Gastroenterology, Cedars-Sinai Medical Center, and USC Research Center for Liver Diseases, Keck School of Medicine; University of Southern California; Los Angeles CA

Funder

National Institutes of Health

Sanidad Gobierno Vasco 2013

Asociación Española contra el Cáncer

Educación Gobierno Vasco

Program Ramón y Cajal

Sanidad Gobierno Vasco 2012

CIBERehd is funded by the Instituto de Salud Carlos III

Publisher

Wiley

Subject

Hepatology